{"id":22522,"date":"2023-09-27T05:29:17","date_gmt":"2023-09-27T05:29:17","guid":{"rendered":"https:\/\/microloannexus.com\/investing\/insulets-financial-journey-marked-by-fed-rate-hikes-and-new-diabetes-treatments\/"},"modified":"2023-09-27T05:29:18","modified_gmt":"2023-09-27T05:29:18","slug":"insulets-financial-journey-marked-by-fed-rate-hikes-and-new-diabetes-treatments","status":"publish","type":"post","link":"https:\/\/microloannexus.com\/?p=22522","title":{"rendered":"Insulet’s financial journey marked by Fed rate hikes and new diabetes treatments"},"content":{"rendered":"
\n
\n

\u00a9 Pavlo Gonchar \/ SOPA Images\/Sipa via Reuters Connect <\/span>
\n<\/i>\n<\/div>\n

Insulet (NASDAQ: NASDAQ:), the medical device company known for its Omnipod insulin pump system, has been facing financial challenges since the Federal Reserve initiated rate hikes in June 2022. The stock has been under pressure due to investors’ concerns about new diabetes treatments potentially impacting the sales of Insulet’s insulin pumps.<\/p>\n

Despite the market volatility, Insulet has demonstrated resilience by maintaining a superior Sharpe Ratio compared to the , a trend that has been consistent since 2017. This information was gleaned from an analysis of the Insulet Valuation Ratios Comparison dashboard.<\/p>\n

However, an examination of the company’s financials reveals some areas of concern. As per the Insulet Operating Income Comparison dashboard, the company’s operating margin has decreased from 6.7% in 2019 to 5.8% currently. This contraction in margin is despite revenue growth attributed largely to its Omnipod system.<\/p>\n

In terms of debt management, Insulet’s total debt has seen a significant increase, rising from $0.9 billion in 2019 to its current level of $1.4 billion. On a more positive note, the company’s cash reserves have also grown during this period, increasing from $376 million in 2019 to $675 million now.<\/p>\n

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.<\/em><\/p>\n<\/div>\n

Read the full article here<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

\u00a9 Pavlo Gonchar \/ SOPA Images\/Sipa via Reuters Connect Insulet (NASDAQ: NASDAQ:), the medical device company known for its Omnipod insulin pump system, has been facing financial challenges since the Federal Reserve initiated rate hikes in June 2022. The stock has been under pressure due to investors’ concerns about new diabetes treatments potentially impacting the<\/p>\n","protected":false},"author":1,"featured_media":9965,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[49],"tags":[32],"class_list":{"0":"post-22522","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investing","8":"tag-featured"},"yoast_head":"\nInsulet's financial journey marked by Fed rate hikes and new diabetes treatments | Micro Loan Nexus<\/title>\n<meta name=\"description\" content=\"\u00a9 Pavlo Gonchar \/ SOPA Images\/Sipa via Reuters Connect Insulet (NASDAQ: NASDAQ:), the medical device company known for its Omnipod insulin pump system,\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/microloannexus.com\/?p=22522\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Insulet's financial journey marked by Fed rate hikes and new diabetes treatments | Micro Loan Nexus\" \/>\n<meta property=\"og:description\" content=\"\u00a9 Pavlo Gonchar \/ SOPA Images\/Sipa via Reuters Connect Insulet (NASDAQ: NASDAQ:), the medical device company known for its Omnipod insulin pump system,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/microloannexus.com\/?p=22522\" \/>\n<meta property=\"og:site_name\" content=\"Micro Loan Nexus\" \/>\n<meta property=\"article:published_time\" content=\"2023-09-27T05:29:17+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-09-27T05:29:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/SP500StandardandPoors500Index_800x533_L_1657544297.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"News Room\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"News Room\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/microloannexus.com\/?p=22522#article\",\"isPartOf\":{\"@id\":\"https:\/\/microloannexus.com\/?p=22522\"},\"author\":{\"name\":\"News Room\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a\"},\"headline\":\"Insulet’s financial journey marked by Fed rate hikes and new diabetes treatments\",\"datePublished\":\"2023-09-27T05:29:17+00:00\",\"dateModified\":\"2023-09-27T05:29:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/microloannexus.com\/?p=22522\"},\"wordCount\":230,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/microloannexus.com\/#organization\"},\"keywords\":[\"Featured\"],\"articleSection\":[\"Investing\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/microloannexus.com\/?p=22522#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/microloannexus.com\/?p=22522\",\"url\":\"https:\/\/microloannexus.com\/?p=22522\",\"name\":\"Insulet's financial journey marked by Fed rate hikes and new diabetes treatments | Micro Loan Nexus\",\"isPartOf\":{\"@id\":\"https:\/\/microloannexus.com\/#website\"},\"datePublished\":\"2023-09-27T05:29:17+00:00\",\"dateModified\":\"2023-09-27T05:29:18+00:00\",\"description\":\"\u00a9 Pavlo Gonchar \/ SOPA Images\/Sipa via Reuters Connect Insulet (NASDAQ: NASDAQ:), the medical device company known for its Omnipod insulin pump system,\",\"breadcrumb\":{\"@id\":\"https:\/\/microloannexus.com\/?p=22522#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/microloannexus.com\/?p=22522\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/microloannexus.com\/?p=22522#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/microloannexus.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Insulet’s financial journey marked by Fed rate hikes and new diabetes treatments\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/microloannexus.com\/#website\",\"url\":\"https:\/\/microloannexus.com\/\",\"name\":\"Solutions For Real\",\"description\":\"Latest Finance News and Updates\",\"publisher\":{\"@id\":\"https:\/\/microloannexus.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/microloannexus.com\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/microloannexus.com\/#organization\",\"name\":\"Solutions For Real\",\"url\":\"https:\/\/microloannexus.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png\",\"contentUrl\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png\",\"width\":690,\"height\":64,\"caption\":\"Solutions For Real\"},\"image\":{\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a\",\"name\":\"News Room\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/microloannexus.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png\",\"contentUrl\":\"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png\",\"caption\":\"News Room\"},\"sameAs\":[\"https:\/\/microloannexus.com\"],\"url\":\"https:\/\/microloannexus.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Insulet's financial journey marked by Fed rate hikes and new diabetes treatments | Micro Loan Nexus","description":"\u00a9 Pavlo Gonchar \/ SOPA Images\/Sipa via Reuters Connect Insulet (NASDAQ: NASDAQ:), the medical device company known for its Omnipod insulin pump system,","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/microloannexus.com\/?p=22522","og_locale":"en_US","og_type":"article","og_title":"Insulet's financial journey marked by Fed rate hikes and new diabetes treatments | Micro Loan Nexus","og_description":"\u00a9 Pavlo Gonchar \/ SOPA Images\/Sipa via Reuters Connect Insulet (NASDAQ: NASDAQ:), the medical device company known for its Omnipod insulin pump system,","og_url":"https:\/\/microloannexus.com\/?p=22522","og_site_name":"Micro Loan Nexus","article_published_time":"2023-09-27T05:29:17+00:00","article_modified_time":"2023-09-27T05:29:18+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/SP500StandardandPoors500Index_800x533_L_1657544297.jpg","type":"image\/jpeg"}],"author":"News Room","twitter_card":"summary_large_image","twitter_misc":{"Written by":"News Room","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/microloannexus.com\/?p=22522#article","isPartOf":{"@id":"https:\/\/microloannexus.com\/?p=22522"},"author":{"name":"News Room","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a"},"headline":"Insulet’s financial journey marked by Fed rate hikes and new diabetes treatments","datePublished":"2023-09-27T05:29:17+00:00","dateModified":"2023-09-27T05:29:18+00:00","mainEntityOfPage":{"@id":"https:\/\/microloannexus.com\/?p=22522"},"wordCount":230,"commentCount":0,"publisher":{"@id":"https:\/\/microloannexus.com\/#organization"},"keywords":["Featured"],"articleSection":["Investing"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/microloannexus.com\/?p=22522#respond"]}]},{"@type":"WebPage","@id":"https:\/\/microloannexus.com\/?p=22522","url":"https:\/\/microloannexus.com\/?p=22522","name":"Insulet's financial journey marked by Fed rate hikes and new diabetes treatments | Micro Loan Nexus","isPartOf":{"@id":"https:\/\/microloannexus.com\/#website"},"datePublished":"2023-09-27T05:29:17+00:00","dateModified":"2023-09-27T05:29:18+00:00","description":"\u00a9 Pavlo Gonchar \/ SOPA Images\/Sipa via Reuters Connect Insulet (NASDAQ: NASDAQ:), the medical device company known for its Omnipod insulin pump system,","breadcrumb":{"@id":"https:\/\/microloannexus.com\/?p=22522#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/microloannexus.com\/?p=22522"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/microloannexus.com\/?p=22522#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/microloannexus.com\/"},{"@type":"ListItem","position":2,"name":"Insulet’s financial journey marked by Fed rate hikes and new diabetes treatments"}]},{"@type":"WebSite","@id":"https:\/\/microloannexus.com\/#website","url":"https:\/\/microloannexus.com\/","name":"Solutions For Real","description":"Latest Finance News and Updates","publisher":{"@id":"https:\/\/microloannexus.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/microloannexus.com\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/microloannexus.com\/#organization","name":"Solutions For Real","url":"https:\/\/microloannexus.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/","url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png","contentUrl":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/sf-logo-1.png","width":690,"height":64,"caption":"Solutions For Real"},"image":{"@id":"https:\/\/microloannexus.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/e2d3b62d35ac325be68540d68dc6660a","name":"News Room","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/microloannexus.com\/#\/schema\/person\/image\/","url":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png","contentUrl":"https:\/\/microloannexus.com\/wp-content\/uploads\/2023\/08\/avatar_user_1_1691264579-96x96.png","caption":"News Room"},"sameAs":["https:\/\/microloannexus.com"],"url":"https:\/\/microloannexus.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/22522","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=22522"}],"version-history":[{"count":1,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/22522\/revisions"}],"predecessor-version":[{"id":22523,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/posts\/22522\/revisions\/22523"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=\/wp\/v2\/media\/9965"}],"wp:attachment":[{"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=22522"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=22522"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/microloannexus.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=22522"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}